2 recruiting, 1 enrolling by invitation. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Enrolling by invitation 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Coronary Arterial Disease (CAD): new trials by email Literature Review of Coronary Arterial Disease (CAD) trials Research Report on Coronary Arterial Disease (CAD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease atenolol, Metoprolol tartrate, Ivabradine - Coronary Arterial Disease (CAD), Ischemic Heart Disease (IHD) | Phase 2 / Phase 3 | Enrolling by invitation | Gødstrup Hospital | 350 | 2025-12-15 | 2025-12-17 |
| Focused Orticumab Research for Treating Inflammation in Coronary Arteries Orticumab, Placebo - Acute Coronary Syndromes, Coronary Arterial Disease (CAD) | Phase 2 | Recruiting | Abcentra | 240 | 2025-08-11 | 2026-01-27 |
| Study of Sivelestat Sodium in OPCABG Sivelestat Sodium injection 2 h after OPCABG for 72 h, Saline (0.9% NaCl) - Coronary Heart Disease, Coronary Artery Disease | Phase 2 | Recruiting | Affiliated Hospital of Nantong University | 62 | 2025-08-01 | 2025-08-12 |
Acute Coronary Syndrome (1) · Coronary Artery Disease (1) · Coronary Disease (1) · Heart Diseases (1) · Inflammation (1) · Myocardial Infarction (1) · Myocardial Ischemia (1)
Cardiovascular Diseases (3) · Vascular Diseases (3) · Heart Diseases (2) · Myocardial Ischemia (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Infarction (1) · Ischemia (1) · Necrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Atenolol (1) · Ivabradine (1) · MLDL1278A (1) · Metoprolol (1) · Sodium Chloride (1)
Abcentra (1) · Affiliated Hospital of Nantong University (1) · Gødstrup Hospital (1)
China (1) · Czechia (1) · Denmark (1) · Hungary (1) · Italy (1) · Poland (1) · Romania (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)
Simon Winther, MD, PhD (1) · Weizhang Xiao, Dr. (1)
PMID 12595539, PMID 20464430, PMID 24241342, PMID 27536731, PMID 31813921, PMID 35266173, PMID 36389323, PMID 38769746, PMID 38811097, PMID 38886709
2025 (1)